| Style | Citing Format |
|---|---|
| MLA | Aarabi SS, et al.. "Prevalence, Predictors, and Clinical Relevance of Drug–Drug Interactions in Outpatient Prescribing: A National Cross-Sectional Study." PLOS ONE, vol. 21, no. 4 April, 2026, pp. -. |
| APA | Aarabi SS, Semnani F, Aminzade Z, Mehrizi R, Gholamnezhad M, Armand R, Armand N, Ghamkhar L (2026). Prevalence, Predictors, and Clinical Relevance of Drug–Drug Interactions in Outpatient Prescribing: A National Cross-Sectional Study. PLOS ONE, 21(4 April), -. |
| Chicago | Aarabi SS, Semnani F, Aminzade Z, Mehrizi R, Gholamnezhad M, Armand R, Armand N, Ghamkhar L. "Prevalence, Predictors, and Clinical Relevance of Drug–Drug Interactions in Outpatient Prescribing: A National Cross-Sectional Study." PLOS ONE 21, no. 4 April (2026): -. |
| Harvard | Aarabi SS et al. (2026) 'Prevalence, Predictors, and Clinical Relevance of Drug–Drug Interactions in Outpatient Prescribing: A National Cross-Sectional Study', PLOS ONE, 21(4 April), pp. -. |
| Vancouver | Aarabi SS, Semnani F, Aminzade Z, Mehrizi R, Gholamnezhad M, Armand R, et al.. Prevalence, Predictors, and Clinical Relevance of Drug–Drug Interactions in Outpatient Prescribing: A National Cross-Sectional Study. PLOS ONE. 2026;21(4 April):-. |
| BibTex | @article{ author = {Aarabi SS and Semnani F and Aminzade Z and Mehrizi R and Gholamnezhad M and Armand R and Armand N and Ghamkhar L}, title = {Prevalence, Predictors, and Clinical Relevance of Drug–Drug Interactions in Outpatient Prescribing: A National Cross-Sectional Study}, journal = {PLOS ONE}, volume = {21}, number = {4 April}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Aarabi SS AU - Semnani F AU - Aminzade Z AU - Mehrizi R AU - Gholamnezhad M AU - Armand R AU - Armand N AU - Ghamkhar L TI - Prevalence, Predictors, and Clinical Relevance of Drug–Drug Interactions in Outpatient Prescribing: A National Cross-Sectional Study JO - PLOS ONE VL - 21 IS - 4 April SP - EP - PY - 2026 ER - |